Free Trial
ETR:EVT

Evotec (EVT) Stock Price, News & Analysis

Evotec logo
€7.93 -0.06 (-0.75%)
As of 01/20/2025

About Evotec Stock (ETR:EVT)

Key Stats

Today's Range
€7.88
€8.15
50-Day Range
€7.74
€10.50
52-Week Range
€5.06
€21.69
Volume
424,804 shs
Average Volume
1.36 million shs
Market Capitalization
$1.41 billion
P/E Ratio
N/A
Dividend Yield
2.63%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas, such as autoimmune diseases, cancer, CNS diseases, diabetes, fibrosis, immunology, infectious diseases, kidney diseases, liver diseases, pain and inflammation, rare diseases, respiratory diseases, tuberculosis, and women's health. It has collaboration agreements with SK bioscience, JingXin, Carrick Therapeutics, Sernova, Topas Therapeutics, Exscientia, CONBA Group, Centrexion, Sanofi/NIH, Kazia Therapeutics, Bristol Myers Squibb, Topas Therapeutics, Immunitas, Exscientia, and Bayer, as well as a strategic partnership with Dewpoint Therapeutics to advance its portfolio targeting biomolecular condensates as a novel domain for therapeutic intervention towards the clinic. The company was formerly known as Evotec AG and changed its name to Evotec SE in April 2019. Evotec SE was incorporated in 1993 and is headquartered in Hamburg, Germany.

Receive EVT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Evotec and its competitors with MarketBeat's FREE daily newsletter.

EVT Stock News Headlines

Evotec Aktie: Ein Abstieg ist zu befürchten
Evotec Aktie: Rückblick auf frühere Prognosen
“Fed Proof” Your Bank Account with THESE 4 Simple Steps
Starting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide. It will give them unprecedented powers to control your bank account.
Evotec Aktie: Erfolgreich in den Tag!
Evotec Aktie: Absturzgefahr oder Kaufsignale in Sicht?
Deal-Aus verdaut? Evotec sucht Stabilität
See More Headlines

EVT Stock Analysis - Frequently Asked Questions

Evotec's stock was trading at €8.20 at the start of the year. Since then, EVT shares have decreased by 3.2% and is now trading at €7.93.
View the best growth stocks for 2025 here
.

Based on aggregate information from My MarketBeat watchlists, some other companies that Evotec investors own include Bank of America (BAC), Evotec (EVTCY), Intel (INTC), NVIDIA (NVDA), AbbVie (ABBV), Applied Materials (AMAT) and KLA (KLAC).

Industry, Sector and Symbol

Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
Financial Services
CIK
N/A
Fax
N/A
Employees
5,061
Year Founded
N/A

Profitability

Net Income
$-170,690,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$788.44 million
Cash Flow
€2.30 per share
Book Value
€5.70 per share

Miscellaneous

Free Float
N/A
Market Cap
$1.41 billion
Optionable
Not Optionable
Beta
1.05
7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors Cover

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

This page (ETR:EVT) was last updated on 1/21/2025 by MarketBeat.com Staff
From Our Partners